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Dr Matthew Mell (Madison, Wis). Could you speculate on
the influence of smoking in your patient cohort and whether it may
have acted as a confounding variable if a family smoking history was
more prevalent?
Dr Hultgren. Well, that’s impossible to say, since it’s a
register-based study. Looking at the comorbid conditions, you get
a hint that probably smoking prevalence is much higher in the case
group than in the control group. It’s well known that smoking
habits as well as dietary habits is inherited too through a social
pattern. So probably it is much more prevalent in the case group.
Dr Louis Nguyen (Boston, Mass). I have a question regard-
ing aneurysm screening in Sweden, because I am concerned that
the likelihood for detection of AAA is different in your case group
versus control group. A patient with a known aneurysm will more
likely be told to have his relatives checked for an aneurysm as well.
This scenario would then produce a higher incidence of relatives
with AAA. For patients with no known AAA, their relatives would
not have any reason to be screened unless there was a broad
program in place. Can you tell us if AAA screening is routine and
widespread in Sweden? Also, could you comment on whether or
not the likelihood for detection of aneurysms in the relatives of
your two groups was equivalent?
Dr Hultgren. Yes, I think that’s an important point, and
we’ve discussed that quite a lot. But we think at least by adjusting
for the comorbid conditions you get rid of some of the problemwith over-diagnosing comorbid patients. Maybe it isn’t that bad
that we actually do screen first-degree relatives more, because they
are probably at a much higher risk, so maybe that’s actually quite
motivated.
Dr J. Black (Baltimore, Md). Did you look at the age of
presentation of the index cases with aneurysms and the number of
affected relatives? The implication being that younger patients with
more affected relatives might have a genetic syndrome and would
prompt referral. Do you have that data available within the set?
Dr Hultgren. In the analysis of subgroups, we did get a
higher odds ratio (OR) for younger patients having a higher risk
for the first-degree relative, it didn’t become significant compared
to the OR of 1.8 in the older age groups. In the analysis of the
thoracic patients, younger age was a higher risk to develop disease
than in the AAA group.
Dr K.W. Johnston (Toronto, Ontario, Canada). What ge-
netic testing do you consider doing in a patient with a positive
family history of aneurysm to try and determine if they do indeed
have an increased risk?
DrHultgren.Well, there have been some studies internation-
ally looking at genes and genetic pathways, and nobody has really
succeeded in finding one or two especially important genes. We
will start a national screening program in a couple of years, and we
are going to do a genetic screening based on that, let me come back
in 3 years and I’ll tell you more about it.
